(Q44126179)

30 November 2017

title

Protection against rotavirus shedding after intranasal immunization of mice with a chimeric VP6 protein does not require intestinal IgA. (English)

1 reference

30 November 2017

0 references

Monica M McNeal

1

1 reference

30 November 2017

Susan C Stone

2

1 reference

30 November 2017

Mitali Basu

3

1 reference

30 November 2017

Judy A Bean

4

1 reference

30 November 2017

John D Clements

5

1 reference

30 November 2017

Barbara A Hendrickson

6

1 reference

30 November 2017

Anthony H-C Choi

7

1 reference

30 November 2017

Richard L Ward

8

1 reference

30 November 2017

language of work or name

English

0 references

publication date

10 January 2006

1 reference

30 November 2017

1 reference

30 November 2017

volume

346

1 reference

30 November 2017

issue

2

1 reference

30 November 2017

page(s)

338-347

1 reference

Magnitude of serum and intestinal antibody responses induced by sequential replicating and nonreplicating rotavirus vaccines in gnotobiotic pigs and correlation with protection

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.016

Immunogenicity and protective efficacy of rotavirus 2/6-virus-like particles produced by a dual baculovirus expression vector and administered intramuscularly, intranasally, or orally to mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.016

Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.016

Intranasal or oral immunization of inbred and outbred mice with murine or human rotavirus VP6 proteins protects against viral shedding after challenge with murine rotaviruses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.016

The level of protection against rotavirus shedding in mice following immunization with a chimeric VP6 protein is dependent on the route and the coadministered adjuvant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.016

Determination of the duration of a primary immune response and the ID50 of ALA rabbit rotavirus in rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.016

Nasal immunization of mice with virus-like particles protects offspring against rotavirus diarrhea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.016

Rotavirus vaccines: an update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.016

Heterotypic protection following oral immunization with live heterologous rotaviruses in a mouse model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.016

Inhibition of rotavirus replication by a non-neutralizing, rotavirus VP6-specific IgA mAb.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.016

Oral delivery of homologous and heterologous strains of rotavirus to BALB/c mice induces the same profile of cytokine production by spleen cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.016

The future of rotavirus vaccines: a major setback leads to new opportunities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.016

Antibody responses to human rotavirus (HRV) in gnotobiotic pigs following a new prime/boost vaccine strategy using oral attenuated HRV priming and intranasal VP2/6 rotavirus-like particle (VLP) boosting with ISCOM.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.016

Altered hepatic transport of immunoglobulin A in mice lacking the J chain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.016

Systemic and intestinal antibody secreting cell responses and protection in gnotobiotic pigs immunized orally with attenuated Wa human rotavirus and Wa 2/6-rotavirus-like-particles associated with immunostimulating complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.016

Heterotypic protection from rotavirus infection in mice vaccinated with virus-like particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.016

Protective intestinal anti-rotavirus B cell immunity is dependent on alpha 4 beta 7 integrin expression but does not require IgA antibody production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.016

Fecal antibody responses to symptomatic and asymptomatic rotavirus infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.016

Effector functions of antibody and CD8+ cells in resolution of rotavirus infection and protection against reinfection in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.016

CD4 T cells are the only lymphocytes needed to protect mice against rotavirus shedding after intranasal immunization with a chimeric VP6 protein and the adjuvant LT(R192G).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.016

Protection and antibody responses to oral priming by attenuated human rotavirus followed by oral boosting with 2/6-rotavirus-like particles with immunostimulating complexes in gnotobiotic pigs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.016

Protection of the villus epithelial cells of the small intestine from rotavirus infection does not require immunoglobulin A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.016

Global Illness and Deaths Caused by Rotavirus Disease in Children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.016

Heterologous protection induced by the inner capsid proteins of rotavirus requires transcytosis of mucosal immunoglobulins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.016

Protective efficacy of rotavirus 2/6-virus-like particles combined with CT-E29H, a detoxified cholera toxin adjuvant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.016

Role for T cell-independent B cell activity in the resolution of primary rotavirus infection in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.016

Mechanisms of protection against rotavirus in humans and mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.016

Possible Mechanisms of Protection Elicited by Candidate Rotavirus Vaccines as Determined with the Adult Mouse Model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.016

Lack of correlation between serum rotavirus antibody titers and protection following vaccination with reassortant RRV vaccines. US Rotavirus Vaccine Efficacy Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.016

Evidence that protection against rotavirus diarrhea after natural infection is not dependent on serotype-specific neutralizing antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.016

Evidence that active protection following oral immunization of mice with live rotavirus is not dependent on neutralizing antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.016

Serologic correlates of immunity in a tetravalent reassortant rotavirus vaccine trial. US Rotavirus Vaccine Efficacy Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.016

Induction of mucosal immune responses and protection against enteric viruses: rotavirus infection of gnotobiotic pigs as a model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.016

Intranasal administration of 2/6-rotavirus-like particles with mutant Escherichia coli heat-labile toxin (LT-R192G) induces antibody-secreting cell responses but not protective immunity in gnotobiotic pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.016

Protective immunity and antibody-secreting cell responses elicited by combined oral attenuated Wa human rotavirus and intranasal Wa 2/6-VLPs with mutant Escherichia coli heat-labile toxin in gnotobiotic pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.016

Antibody-independent protection against rotavirus infection of mice stimulated by intranasal immunization with chimeric VP4 or VP6 protein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.016

7 January 2021

Subunit rotavirus vaccine administered parenterally to rabbits induces active protective immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.016

7 January 2021

Serologic and mucosal immune response to rotavirus infection in the rabbit model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.016

7 January 2021

Evidence that resolution of rotavirus infection in mice is due to both CD4 and CD8 cell-dependent activities

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.016

7 January 2021

Antibody-dependent and -independent protection following intranasal immunization of mice with rotavirus particles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.016

7 January 2021

10.1016/J.VIROL.2005.11.016

Identifiers

DOI

1 reference

30 November 2017

1 reference